发明授权
- 专利标题: Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
- 专利标题(中): 药理活性化合物,其制备方法和含有它们的组合物
-
申请号: US126911申请日: 1987-11-27
-
公开(公告)号: US4963590A公开(公告)日: 1990-10-16
- 发明人: Reijo J. Backstrom , Kalevi E. Heinola , Erkki J. Honkanen , Seppo K. Kaakkola , Pekka J. Kairisalo , Inge-Britt Y. Linden , Pekka T. Mannisto , Erkki A. O. Nissinen , Pentti Pohto , Aino K. Pippuri , Jarmo J. Pystynen
- 申请人: Reijo J. Backstrom , Kalevi E. Heinola , Erkki J. Honkanen , Seppo K. Kaakkola , Pekka J. Kairisalo , Inge-Britt Y. Linden , Pekka T. Mannisto , Erkki A. O. Nissinen , Pentti Pohto , Aino K. Pippuri , Jarmo J. Pystynen
- 申请人地址: FIX
- 专利权人: Orion-yhtyma Oy
- 当前专利权人: Orion-yhtyma Oy
- 当前专利权人地址: FIX
- 优先权: FIX864875 19861128
- 主分类号: C07C27/00
- IPC分类号: C07C27/00 ; A61K31/00 ; A61K31/04 ; A61K31/045 ; A61K31/047 ; A61K31/05 ; A61K31/06 ; A61K31/075 ; A61K31/085 ; A61K31/11 ; A61K31/12 ; A61K31/13 ; A61K31/135 ; A61K31/165 ; A61K31/19 ; A61K31/215 ; A61K31/235 ; A61K31/275 ; A61K31/33 ; A61K31/335 ; A61K31/357 ; A61K31/36 ; A61K31/395 ; A61K31/40 ; A61K31/44 ; A61K31/4409 ; A61K31/4418 ; A61K31/443 ; A61K31/445 ; A61K31/4468 ; A61K31/451 ; A61K31/47 ; A61K31/495 ; A61P9/12 ; A61P25/00 ; A61P25/24 ; A61P25/26 ; A61P25/28 ; A61P43/00 ; C07C20060101 ; C07C39/08 ; C07C39/24 ; C07C39/26 ; C07C39/373 ; C07C43/20 ; C07C43/23 ; C07C45/00 ; C07C45/56 ; C07C45/67 ; C07C45/74 ; C07C47/52 ; C07C47/565 ; C07C47/575 ; C07C49/20 ; C07C49/245 ; C07C49/747 ; C07C49/76 ; C07C49/83 ; C07C49/835 ; C07C49/84 ; C07C59/40 ; C07C59/52 ; C07C59/56 ; C07C59/64 ; C07C59/68 ; C07C59/90 ; C07C65/00 ; C07C65/03 ; C07C65/21 ; C07C67/00 ; C07C69/017 ; C07C69/035 ; C07C69/73 ; C07C69/76 ; C07C205/20 ; C07C205/22 ; C07C205/23 ; C07C205/26 ; C07C205/34 ; C07C205/37 ; C07C205/43 ; C07C205/45 ; C07C205/56 ; C07C205/57 ; C07C213/00 ; C07C231/00 ; C07C233/00 ; C07C233/12 ; C07C235/44 ; C07C235/54 ; C07C235/66 ; C07C239/00 ; C07C253/00 ; C07C255/37 ; C07C255/53 ; C07C301/00 ; C07C309/65 ; C07C311/15 ; C07C317/22 ; C07D207/32 ; C07D207/325 ; C07D207/333 ; C07D211/14 ; C07D211/22 ; C07D211/30 ; C07D211/32 ; C07D211/58 ; C07D213/30 ; C07D215/14 ; C07D295/08 ; C07D295/13 ; C07D295/18 ; C07D295/185 ; C07D317/52 ; C07D317/62 ; C07D319/24 ; C07D405/04 ; C07D405/06
摘要:
Pharmacologically active catechol derivatives of formula I ##STR1## wherein R.sub.1 and R.sub.2 independently comprise hydrogen, alkyl, acyl, optionally substituted aroyl, lower alkylsulfonyl or alkylcabamoyl or taken together form a lower alkylidene or cycloalkylidene, X comprises an electronegative substituent such as halogen, nitro, cyano, lower alkylsulfonyl, sulfonamido, aldehyde, caboxyl or trifluoromethyl and R.sub.3 comprises hydrogen, halogen, hydroxy alkyl, amino, nitro, cyano, trifluoromethyl, lower alkylsulfonyl, sulfonamide, aldehyde, alkyl carbonyl, aralkylidene carbonyl or carboxyl or a group selected from ##STR2## wherein R.sub.4 comprises hydrogen, alkyl, cyano, carboxyl or acyl and R.sub.5 comprises hydrogen, cyano, carboxyl, alkoxycarbonyl, carboxyalkenyl, nitro, acyl, optionally substituted aroyl or heteroaroyl, hydroxyalkyl or carboxyalkyl or R.sub.4 and R.sub.5 together form a five to seven membered substituted cycloalkanone ring;--(CO).sub.n (CH.sub.2).sub.m --CORwherein n is 0-1 and m is 0-7 and R comprises hydroxy, alkyl, carboxyalkyl, optionally substituted alkene, alkoxy or optionally substituted amino; ##STR3## wherein R.sub.8 and R.sub.9 independently comprise hydrogen or one of the following optionally substituted groups; alkyl, alkenyl, alkynyl, cycloalkyl, aralkyl, or together form an optionally substituted piperidyl group;--NH--CO--R.sub.10wherein R.sub.10 comprises a substituted alkyl group.
公开/授权文献
- US5994993A Fuse indicator label 公开/授权日:1999-11-30
信息查询